Clearside Biomedical, Inc.CLSDNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P8
Near historical low
vs 3Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -10.82% |
| 2023 | 6.19% |
| 2022 | 5.90% |
| 2021 | 22.98% |
| 2020 | -3.74% |
| 2019 | -77.07% |
| 2018 | 39.22% |
| 2017 | 152.14% |
| 2016 | 80.77% |
| 2015 | 60.82% |